glp 1 vs sglt2 Combining GLP-1 Receptor Agonists and Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique | Diabetes Therapy GLP-1 Receptor Agonists and SGLT2
Description
Endocrinology, 159(2), 665675
Anjana Chhabra
Patients must be a US citizen or legal resident and must meet all other eligibility requirements
These drugs are meant to be taken long-term, and stopping them too soon may result in rebound weight gain
This is due to the required injection, costs, and side effects as potential barriers to growth
